COMPASS THERAPEUTICS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | -21.6% | -21.6% | -19.6% |
| FY2023 | -28.6% | -28.6% | -27.1% |
| FY2024 | -39.4% | -39.4% | -35.2% |
| FY2025 | -33.8% | -33.8% | -30.3% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | -21.6% | -21.6% | -19.6% |
| FY2023 | -28.6% | -28.6% | -27.1% |
| FY2024 | -39.4% | -39.4% | -35.2% |
| FY2025 | -33.8% | -33.8% | -30.3% |